Facebook Inc. (FB) Graph Search Raises Privacy Concerns

Page 1 of 2

Facebook Inc. (NASDAQ:FB) was pleased, and almost giddy, when it announced the gradual rollout of its Graph Search feature, which many think will evolve into  a full-fledged Internet search engine to compete with Google Inc. (NASDAQ:GOOG) and Bing by Microsoft Corporation (NASDAQ:MSFT). As it is currently designed, Facebook users can conduct searches within Facebook to locate friends, photos and posts that are relevant to the search query.

While many posts and photos are public  or at least can be seen by friends, there are secutiry experts who are speaking out against Graph Search, warning Facebook Inc. (NASDAQ:FB) that if they don’t re-set their privacy settings, there might be too much information available for searching – and a user’s profile may come up in an undesirable or potentially harmful way in terms of reputation.

Facebook Inc (NASDAQ:FB)While users of Facebook Inc. (NASDAQ:FB) can use Graph Search to get personalized results to queries like “Itaian restaurants in Dallas that my friends like,” there are other search queries that may lead to potential embarrassment or make some users targets. Not only are profiles scanned for search results, posts, videos and even “likes” can be highlighted and used to gather results. And to some security experts, it could be those “likes” that might make some users susceptible.

One such expert used some example search results like “married people who like prostitutes,” or “current employers of people who like racism.” Yes, even “likes” won’t be so anonymous to Graph Search, once it is fully implemented. There are also are openings where certain government entities in foreign countries could use the search to find dissidents, as another example.

Does Graph Search change the relationship between Facebook and its users with this new feature?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!